An endogenous antimicrobial peptide studied in innate immunity, inflammatory signaling and wound biology. This record separates established identity and source-linked research context from protocol or commercial fields that are not yet supportable.
FEMETRIC RECORD · PUBLICLL-37
Immune SupportInflammationWound Repair
Status
Investigational
Related
3
Sources
1
UPDATED 2026-09-13
01
Protocol references
SOURCE-LINKED
PUBLISHED STUDY
Source-linked research context
No universal administration structure is inferred from the indexed literature. Open the source for the population, intervention and study design.
Route
Topical research
Frequency
See indexed source
Duration
Not indexed
Escalation
Not established
Stage detail pending source extractionStarting and target doses are indexed. Intermediate steps are intentionally not inferred.
PUBLISHED STUDYClinical study record, 2023Verified 2026-09-13
LL-37 has context-dependent antimicrobial and immunomodulatory activity. Its biology is complex, and higher activity is not universally beneficial across inflammatory conditions.
Mechanism summaries are stored with field-level source provenance for editorial audit.
07
Related research goals
08
Related peptides
01PEPTIDE
Thymosin Alpha-1
A thymic peptide with human clinical research across infectious, immune and oncology contexts; regulatory status varies by country.
Immune SupportInflammationCellular Repair
02PEPTIDE
KPV
A three-amino-acid melanocortin fragment studied in intestinal transport and inflammatory models.
GutBarrier FunctionInflammation
03PEPTIDE
TB-500
A synthetic N-acetylated fragment associated with thymosin beta-4 research and anti-doping analysis.